Arbutus Biopharma Corporation (ABUS) has a market capitalization of $850.33M and trades at $4.35. The 52-week range is 2.71-5.1.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -25.6, Earnings Per Share (EPS) of $-0.17, annual revenue of $14.08M.
The stock has a beta of 0.74, operates in the Healthcare sector.
